Mice lacking ACSL1 specifically in adipose tissue have defects in adipose FFA oxidation [9], whereas those unable to express ACSL1 in heart ventricles show compensatory catabolism of glucose and amino acids leading to mTOR activation and cardiac hypertrophy without lipid accumulation or dysfunction [14]. Here, ACSL1 is linked to cardiac hypertrophy.